Total Payments
$3,605
2024 Payments
$418.22
Companies
18
Transactions
100
Medicare Patients
9,677
Medicare Billing
$774,961
Payment Breakdown by Category
Food & Beverage$3,525 (97.8%)
Education$79.99 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,525 | 99 | 97.8% |
| Education | $79.99 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $717.73 | 19 | $0 (2024) |
| Celgene Corporation | $421.37 | 6 | $0 (2019) |
| Lilly USA, LLC | $394.24 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $320.72 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $271.42 | 10 | $0 (2022) |
| Allergan Inc. | $244.51 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $220.71 | 7 | $0 (2024) |
| Genentech USA, Inc. | $193.85 | 5 | $0 (2018) |
| Amgen Inc. | $176.86 | 9 | $0 (2024) |
| LEO Pharma Inc. | $142.80 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $418.22 | 17 | Janssen Biotech, Inc. ($137.82) |
| 2023 | $394.90 | 17 | LEO Pharma Inc. ($87.58) |
| 2022 | $283.43 | 12 | Sun Pharmaceutical Industries Inc. ($66.49) |
| 2021 | $114.25 | 3 | Lilly USA, LLC ($94.70) |
| 2020 | $79.97 | 3 | Janssen Biotech, Inc. ($36.05) |
| 2019 | $272.41 | 5 | Celgene Corporation ($137.48) |
| 2018 | $1,351 | 26 | AbbVie, Inc. ($345.22) |
| 2017 | $691.10 | 17 | AbbVie, Inc. ($216.18) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.16 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Inflammation | ||||||
| 06/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.89 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Inflammation | ||||||
| 04/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Immunology | ||||||
| 04/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $36.34 | General |
| Category: Immunology | ||||||
| 03/21/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Inflammation | ||||||
| 03/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Inflammation | ||||||
| 02/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: Immunology | ||||||
| 02/08/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Immunology | ||||||
| 02/02/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: DERMATOLOGY | ||||||
| 01/24/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Immunology | ||||||
| 01/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.81 | General |
| Category: Immunology | ||||||
| 11/28/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Inflammation | ||||||
| 10/26/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: DERMATOLOGY | ||||||
| 10/19/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Inflammation | ||||||
| 09/25/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: DERMATOLOGY | ||||||
| 08/24/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Immunology | ||||||
| 07/20/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.81 | General |
| Category: Immunology | ||||||
| 06/22/2023 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 3,037 | 5,736 | $782,520 | $251,947 |
| 2022 | 15 | 2,718 | 5,033 | $703,220 | $230,295 |
| 2021 | 15 | 2,146 | 3,637 | $506,775 | $170,791 |
| 2020 | 14 | 1,776 | 2,722 | $369,753 | $121,927 |
Total Patients
9,677
Total Services
17,128
Medicare Billing
$774,961
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 688 | 913 | $178,035 | $58,726 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 394 | 595 | $163,625 | $56,022 | 34.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 585 | 890 | $133,500 | $38,438 | 28.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 314 | 357 | $82,110 | $26,296 | 32.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 162 | 196 | $44,100 | $17,051 | 38.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 405 | 2,257 | $45,140 | $12,195 | 27.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 39 | 42 | $28,560 | $10,394 | 36.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 101 | 101 | $24,745 | $7,297 | 29.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 148 | 167 | $18,370 | $6,271 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $17,885 | $5,948 | 33.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 29 | 30 | $16,350 | $3,115 | 19.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 61 | 71 | $8,165 | $2,959 | 36.2% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 21 | 23 | $8,970 | $2,958 | 33.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 12 | 15 | $5,325 | $1,906 | 35.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 16 | $4,560 | $1,631 | 35.8% |
| 69100 | Biopsy of ear | Office | 2023 | 14 | 14 | $3,080 | $739.26 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 585 | 839 | $163,605 | $55,089 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 264 | 378 | $103,950 | $35,585 | 34.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 468 | 718 | $107,700 | $31,893 | 29.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 284 | 333 | $76,590 | $26,256 | 34.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 139 | 176 | $39,600 | $15,850 | 40.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 189 | 189 | $46,305 | $13,817 | 29.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 51 | 53 | $36,040 | $12,958 | 36.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 338 | 1,888 | $37,760 | $10,526 | 27.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 186 | 214 | $23,540 | $8,782 | 37.3% |
About Dr. Elizabeth Tocci, MD
Dr. Elizabeth Tocci, MD is a Dermatology healthcare provider based in West Yarmouth, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1073995163.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elizabeth Tocci, MD has received a total of $3,605 in payments from pharmaceutical and medical device companies, with $418.22 received in 2024. These payments were reported across 100 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,525).
As a Medicare-enrolled provider, Tocci has provided services to 9,677 Medicare beneficiaries, totaling 17,128 services with total Medicare billing of $774,961. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location West Yarmouth, MA
- Active Since 06/24/2015
- Last Updated 12/08/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073995163
Products in Payments
- Otezla (Drug) $556.46
- Humira (Biological) $448.16
- COSENTYX (Biological) $271.42
- DUPIXENT DUPILUMAB INJECTION (Biological) $213.98
- TREMFYA (Drug) $198.50
- TALTZ (Drug) $191.15
- Erivedge (Biological) $169.05
- ADBRY (Biological) $142.80
- SKYRIZI (Biological) $128.90
- DUPIXENT (Biological) $125.22
- Tremfya (Drug) $125.00
- Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug) $99.96
- Sotyktu (Drug) $97.90
- BLU-U (Medical Supply) $46.04
- Cimzia (Drug) $34.20
- RINVOQ (Biological) $27.43
- Xolair (Biological) $24.80
- Ameluz (Drug) $23.22
- REMICADE (Biological) $22.21
- VALCHLOR MECHLORETHAMINE (Drug) $21.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.